Everest Medicines Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	14,047	13,065	15,592	6,698	5,375	10,326
Market Cap Growth	-30.89%	-16.21%	132.78%	24.63%	-47.95%	-47.98%
Enterprise Value	12,038	12,132	13,630	4,306	3,712	6,099
Last Close Price	39.98	36.98	48.40	20.90	17.38	34.80
Forward PE	66.30	95.03	-	-	-	-
PS Ratio	7.40	6.88	20.73	48.28	371.66	155778.93
PB Ratio	2.38	2.21	3.60	1.22	0.84	1.43
P/TBV Ratio	3.93	3.65	8.06	2.49	1.45	2.46
EV/Sales Ratio	6.34	6.39	18.12	31.04	256.65	92015.48
Debt / Equity Ratio	0.18	0.18	0.14	0.11	0.10	0.09
Net Debt / Equity Ratio	-0.34	-0.34	-0.25	-0.36	-0.20	-0.36
Net Debt / EBITDA Ratio	8.55	8.55	1.53	2.28	0.80	2.04
Net Debt / FCF Ratio	11.53	11.53	1.38	2.04	0.74	2.53
Asset Turnover	0.29	0.29	0.13	0.02	0.00	0
Inventory Turnover	22.67	22.67	11.01	2.25	0.77	-
Quick Ratio	4.76	4.76	2.51	7.55	3.84	9.84
Current Ratio	4.89	4.89	2.54	7.63	3.92	9.95
Return on Equity (ROE)	-6.35%	-6.35%	-23.04%	-15.90%	-4.28%	-15.84%
Return on Assets (ROA)	-3.65%	-3.65%	-9.09%	-8.59%	-13.24%	-9.29%
Return on Capital Employed (ROCE)	-5.60%	-5.60%	-18.70%	-15.60%	-24.50%	-16.50%
Earnings Yield	-2.36%	-2.54%	-7.11%	-13.89%	-5.20%	-11.99%
FCF Yield	-1.24%	-1.33%	-5.08%	-14.58%	-31.80%	-9.98%
Buyback Yield / Dilution	-4.84%	-4.84%	-2.51%	-5.18%	-1.49%	-243.61%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.